Kindeva is a global powerhouse CDMO dedicated to manufacturing more tomorrows. Leveraging more than 100 years of innovation, Kindeva provides unrivaled expertise at every stage of pulmonary, nasal, injectable, intradermal, and transdermal therapy development and manufacturing. Whether providing holistic analytical support or scaling sterile injectable fill-finish operations, every solution is backed by extensive technological capabilities, deep regulatory knowledge, and state-of-the-art facilities across the U.S. and U.K. Kindeva’s proactive, informed solutions minimize risk and maximize confidence from ideation through commercialization, bringing high-quality products to patients in need, faster. For more information about our leading drug-device CDMO, please visit www.kindevadd.com.